|
August
Wednesday, Aug 25, 2010 Genentech Provides Update on FDA Application for T-DM1 Tuesday, Aug 10, 2010 FDA Approves Longer Use of Valcyte® for Adult Kidney Transplant Patients at High Risk of Developing Cytomegalovirus (CMV) Disease July Tuesday, Jul 20, 2010 Genentech Provides Update From Avastin FDA Advisory Committee Meeting Tuesday, Jul 06, 2010 Genentech Submits Application to FDA for Trastuzumab-DM1 in Previously Treated Advanced HER2-Positive Breast Cancer Thursday, Jul 01, 2010 Second Phase III Study Showed Avastin-Containing Regimen Helped Women with Ovarian Cancer Live Longer Without their Disease Getting Worse June Tuesday, Jun 22, 2010 FDA Approves Lucentis® (Ranibizumab Injection) for the Treatment of Macular Edema Following Retinal Vein Occlusion See the Archives 
 |
